Topic
Private Credit Research
Within the private credit landscape, researchers emphasize the continued importance of private markets and direct lending as essential tools for diversifying portfolios amidst heightened geopolitical uncertainty and credit stress. While direct lending remains supported, analysts advocate for strict selectivity with a bias toward non-cyclical sectors and infrastructure for inflation-linked income. Credit strategies demonstrated resilience with positive returns in early 2026, though a more defensive posture is emerging through the prioritization of Relative Value and Fixed Income Relative Value sub-strategies. Solid corporate fundamentals and projected S&P 500 EPS growth of 20% support the credit outlook, even as high government deficits pose long-term risks to yields and necessitate a focus on shorter-duration fixed income. Additionally, the massive expansion in AI-related demand, with a projected $1.7 trillion TAM by 2030, and the evolution of biotech into a compounding asset class are creating new long-term investment opportunities for credit providers. Collectively, these insights suggest a research direction focused on resilient, innovation-driven sectors to navigate a goldilocks environment disrupted by macro volatility.
4511 reports available
All reports
Page 174 of 188
PC Market Updated C1Q26 Industry and Market Share Data
Goldman Sachs · May 11, 2026
Rockwool 1Q 2026 First Take
Goldman Sachs · May 11, 2026
Bicara Therapeutics 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
Weekly M&A Activity Americas Investment Banks
Goldman Sachs · May 11, 2026
Chasing Momentum Into the Void
The Market Ear · May 11, 2026
Upwork Q1 2026 Review
Goldman Sachs · May 11, 2026
Shyam Metalics and Energy Q4FY26 Results Review
Goldman Sachs · May 11, 2026
Equity Positioning and Key Levels
Goldman Sachs · May 11, 2026
1Q New Guidance Above Expectations: AI Capex Benefits Are Broadening
Goldman Sachs · May 11, 2026
China Cosmetics 2025 1Q26 Wrap
Goldman Sachs · May 11, 2026
Introduce Bepirovirsen From GSK to Enrich Hepatitis Portfolio
Goldman Sachs · May 11, 2026
Middle East Daily
MUFG · May 11, 2026
Sony Group CEO and CFO Meeting
Goldman Sachs Japan Co., Ltd. · May 11, 2026
Debt Capital Markets Update
Piper Sandler · May 11, 2026
Early Morning Reid
Deutsche Bank · May 11, 2026
Resilient or Roaring 20s
UBS · May 11, 2026
Korea and Taiwan: How to Manage AI-Driven Super Surplus
Goldman Sachs · May 11, 2026
Seronegative Approval Reinforces Vyvgart's MG Positioning
Goldman Sachs · May 11, 2026
Goal Kickstart: Sharp Risk Appetite Rebound Led By Tech Momentum Rally
Goldman Sachs · May 11, 2026
Guide to US CPI Risks
Citi · May 11, 2026
UK and European Research at a Glance
RBC Capital Markets · May 11, 2026
Trading Catalysts: Health Care and CPI in Focus
Bank of America · May 11, 2026
Global Chemicals: Middle East Disruption Around the World - Part II
Goldman Sachs · May 11, 2026
Nemetschek: Growth Momentum Continues in Core Segments
Goldman Sachs · May 11, 2026